The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.
For lesions smaller than 4 cm, nephron-sparing surgery has been shown to be oncologically equivalent to radical nephrectomy, albeit with the advantage of preservation of overall renal function. As ...
Full Haplotype-Mismatched Hematopoietic Stem-Cell Transplantation: A Phase II Study in Patients With Acute Leukemia at High Risk of Relapse We treated 52 patients from 1979 to 2002 with a median age ...
Ablative Therapies for Cervical Intraepithelial Neoplasia in Low-Resource Settings: Findings and Key Questions Authors: Miriam L. Cremer [email protected], Gabriel Conzuelo-Rodriguez, William Cherniak, ...
Kalamazoo, MI – Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...
Despite the growing use of fully ablative laser resurfacing for photodamaged skin, standard protocols for managing adverse events remain limited. A newly published international consensus statement ...
KALAMAZOO, Mich.--(BUSINESS WIRE)--Ablative Solutions, Inc., a company pioneering new approaches for the treatment of hypertension, today announced the first close of its $77 million Series D funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results